Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imigran STATdose self-injection in migraine and cluster headache
NCT00356603Phase 3Completed
- Sponsor
- GSK
- Start
- Jun 2006
- Primary completion
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sumatriptan in migraine, Cluster Headache (CH), sponsored by GSK. Started Jun 2006; status: completed.
02
Drugs
sumatriptan
03
Conditions
migraineCluster Headache (CH)
Beyond the preview
Go deeper on NCT00356603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00356603.